Chase Investment Counsel Corp Jazz Pharmaceuticals PLC Transaction History

Chase Investment Counsel Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$87.74 - $152.74 $306,212 - $533,062	-3,490 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$117.65 - $153.73 $410,598 - $536,517	3,490 New	3,490 $520,000
Q4 2018 Feb 04, 2019	SELL	$115.94 - $166.74 $1.76 Million - $2.53 Million	-15,192 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$161.01 - $180.57 $1.94 Million - $2.17 Million	12,037 Added 381.52%	15,192 $2.55 Million
Q2 2018 Aug 07, 2018	SELL	$146.33 - $183.18 $11,706 - $14,654	-80 Reduced 2.47%	3,155 $543,000
Q1 2018 May 07, 2018	BUY	$135.59 - $157.16 $438,633 - $508,412	3,235 New	3,235 $488,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.89B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

Stay updated on Chase Investment Counsel Corp with notifications on news.